Tianjin Medical Journal ›› 2025, Vol. 53 ›› Issue (3): 257-261.doi: 10.11958/20241777
• Clinical Research • Previous Articles Next Articles
YANG Liya(), ZHENG Li, LI Lihong, LI Yayong, MA Jiang
Received:
2024-11-07
Revised:
2025-01-09
Published:
2025-03-15
Online:
2025-03-31
YANG Liya, ZHENG Li, LI Lihong, LI Yayong, MA Jiang. Evaluation of the effect of benserazide combined with respiratory training on post-stroke dysphagia[J]. Tianjin Medical Journal, 2025, 53(3): 257-261.
CLC Number:
组别 | 性别 (男/女) | 年龄/ 岁 | 体质量指数/ (kg/m2) | 病程/ 月 |
---|---|---|---|---|
呼吸训练组 | 26/34 | 62.92±7.05 | 18.98±2.49 | 2.45±0.67 |
联合组 | 25/35 | 64.38±6.31 | 19.35±2.57 | 2.30±0.74 |
χ2或t | 0.034 | 1.201 | 0.800 | 1.157 |
Tab.1 Comparison of general data between the two groups
组别 | 性别 (男/女) | 年龄/ 岁 | 体质量指数/ (kg/m2) | 病程/ 月 |
---|---|---|---|---|
呼吸训练组 | 26/34 | 62.92±7.05 | 18.98±2.49 | 2.45±0.67 |
联合组 | 25/35 | 64.38±6.31 | 19.35±2.57 | 2.30±0.74 |
χ2或t | 0.034 | 1.201 | 0.800 | 1.157 |
组别 | 舌痿缩 | 吞咽缓慢 | 饮水发呛 | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
治疗前 | 治疗后 | t | 治疗前 | 治疗后 | t | 治疗前 | 治疗后 | t | |||||||
呼吸训练组 | 4.75±0.85 | 3.65±0.59 | 8.018* | 5.17±0.87 | 4.70±0.57 | 3.501* | 4.89±0.86 | 3.93±0.49 | 8.895* | ||||||
联合组 | 4.55±0.52 | 1.31±0.23 | 43.773** | 5.46±0.76 | 2.36±0.25 | 31.317** | 5.16±0.68 | 2.55±0.28 | 28.220** | ||||||
t | 1.477 | 28.898** | 0.581 | 28.839** | 1.965 | 18.660** | |||||||||
组别 | 舌苔瘀斑 | 脉搏细涩 | |||||||||||||
治疗前 | 治疗后 | t | 治疗前 | 治疗后 | t | ||||||||||
呼吸训练组 | 2.19±0.27 | 1.83±0.19 | 9.004* | 2.19±0.25 | 1.87±0.19 | 7.351* | |||||||||
联合组 | 2.26±0.34 | 1.01±0.18 | 25.503** | 2.13±0.20 | 1.05±0.12 | 38.222** | |||||||||
t | 1.140 | 24.285** | 1.403 | 27.409** |
Tab.2 Comparison of TCM syndrome scores before and after treatment between the two groups
组别 | 舌痿缩 | 吞咽缓慢 | 饮水发呛 | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
治疗前 | 治疗后 | t | 治疗前 | 治疗后 | t | 治疗前 | 治疗后 | t | |||||||
呼吸训练组 | 4.75±0.85 | 3.65±0.59 | 8.018* | 5.17±0.87 | 4.70±0.57 | 3.501* | 4.89±0.86 | 3.93±0.49 | 8.895* | ||||||
联合组 | 4.55±0.52 | 1.31±0.23 | 43.773** | 5.46±0.76 | 2.36±0.25 | 31.317** | 5.16±0.68 | 2.55±0.28 | 28.220** | ||||||
t | 1.477 | 28.898** | 0.581 | 28.839** | 1.965 | 18.660** | |||||||||
组别 | 舌苔瘀斑 | 脉搏细涩 | |||||||||||||
治疗前 | 治疗后 | t | 治疗前 | 治疗后 | t | ||||||||||
呼吸训练组 | 2.19±0.27 | 1.83±0.19 | 9.004* | 2.19±0.25 | 1.87±0.19 | 7.351* | |||||||||
联合组 | 2.26±0.34 | 1.01±0.18 | 25.503** | 2.13±0.20 | 1.05±0.12 | 38.222** | |||||||||
t | 1.140 | 24.285** | 1.403 | 27.409** |
组别 | 治愈 | 显效 | 有效 | 无效 | 总有效 | |
---|---|---|---|---|---|---|
呼吸训练组 | 7(11.67) | 13(21.67) | 15(25.00) | 25(41.67) | 35(58.33) | |
联合组 | 12(20.00) | 18(30.00) | 25(41.67) | 5(8.33) | 55(91.67) | |
χ2 | 17.778** |
Tab.3 Comparison of clinical efficacy between the two groups
组别 | 治愈 | 显效 | 有效 | 无效 | 总有效 | |
---|---|---|---|---|---|---|
呼吸训练组 | 7(11.67) | 13(21.67) | 15(25.00) | 25(41.67) | 35(58.33) | |
联合组 | 12(20.00) | 18(30.00) | 25(41.67) | 5(8.33) | 55(91.67) | |
χ2 | 17.778** |
组别 | VDS | PAS | 洼田饮水试验 | VFSS | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
治疗前 | 治疗后 | t | 治疗前 | 治疗后 | t | 治疗前 | 治疗后 | t | 治疗前 | 治疗后 | t | |
呼吸训练组 | 48.89±5.48 | 32.18±3.28 | 19.230** | 3.66±0.41 | 2.87±0.32 | 11.097* | 3.29±0.38 | 1.98±0.22 | 22.330** | 2.80±0.06 | 6.56±1.38 | 24.621** |
联合组 | 50.17±5.23 | 21.26±2.35 | 37.784** | 3.59±0.39 | 1.68±0.24 | 38.118** | 3.34±0.59 | 1.07±0.13 | 29.092** | 2.79±0.08 | 7.92±1.62 | 21.004** |
t | 1.310 | 20.910** | 0.824 | 22.978** | 0.636 | 27.600** | 0.272 | 4.951* |
Tab.4 Comparison of VDS, PAS and Kubota drinking test scores between the two groups
组别 | VDS | PAS | 洼田饮水试验 | VFSS | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
治疗前 | 治疗后 | t | 治疗前 | 治疗后 | t | 治疗前 | 治疗后 | t | 治疗前 | 治疗后 | t | |
呼吸训练组 | 48.89±5.48 | 32.18±3.28 | 19.230** | 3.66±0.41 | 2.87±0.32 | 11.097* | 3.29±0.38 | 1.98±0.22 | 22.330** | 2.80±0.06 | 6.56±1.38 | 24.621** |
联合组 | 50.17±5.23 | 21.26±2.35 | 37.784** | 3.59±0.39 | 1.68±0.24 | 38.118** | 3.34±0.59 | 1.07±0.13 | 29.092** | 2.79±0.08 | 7.92±1.62 | 21.004** |
t | 1.310 | 20.910** | 0.824 | 22.978** | 0.636 | 27.600** | 0.272 | 4.951* |
组别 | TC/(mmol/L) | TG/(mmol/L) | ALB/(g/L) | Hb/(g/L) | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
治疗前 | 治疗后 | t | 治疗前 | 治疗后 | t | 治疗前 | 治疗后 | t | 治疗前 | 治疗后 | t | |
呼吸训练组 | 2.58±0.34 | 3.96±0.37 | 19.922** | 1.68±0.21 | 1.96±0.24 | 6.850* | 27.38±2.86 | 36.87±4.72 | 12.283** | 97.63±9.83 | 127.39±12.83 | 15.204** |
联合组 | 2.47±0.29 | 4.27±0.52 | 26.629** | 1.74±0.19 | 2.11±0.22 | 9.184* | 27.19±2.99 | 48.39±5.11 | 29.192** | 98.54±9.92 | 138.84±13.09 | 21.332** |
t | 1.763 | 3.845* | 1.734 | 3.271* | 0.356 | 12.828** | 0.499 | 4.839* |
Tab.5 Comparison of serum TC, TG, ALB and Hb levels between the two groups
组别 | TC/(mmol/L) | TG/(mmol/L) | ALB/(g/L) | Hb/(g/L) | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
治疗前 | 治疗后 | t | 治疗前 | 治疗后 | t | 治疗前 | 治疗后 | t | 治疗前 | 治疗后 | t | |
呼吸训练组 | 2.58±0.34 | 3.96±0.37 | 19.922** | 1.68±0.21 | 1.96±0.24 | 6.850* | 27.38±2.86 | 36.87±4.72 | 12.283** | 97.63±9.83 | 127.39±12.83 | 15.204** |
联合组 | 2.47±0.29 | 4.27±0.52 | 26.629** | 1.74±0.19 | 2.11±0.22 | 9.184* | 27.19±2.99 | 48.39±5.11 | 29.192** | 98.54±9.92 | 138.84±13.09 | 21.332** |
t | 1.763 | 3.845* | 1.734 | 3.271* | 0.356 | 12.828** | 0.499 | 4.839* |
组别 | GDF-15/(ng/L) | S100β/(μg/L) | ||||
---|---|---|---|---|---|---|
治疗前 | 治疗后 | t | 治疗前 | 治疗后 | t | |
呼吸训练组 | 858.37±86.12 | 567.56±57.17 | 20.336** | 0.24±0.06 | 0.31±0.05 | 6.771* |
联合组 | 869.24±87.01 | 421.43±42.53 | 38.013** | 0.23±0.05 | 0.45±0.06 | 23.454** |
t | 0.687 | 15.884** | 0.669 | 13.342** |
Tab.6 Comparison of serum GDF-15 and S100β levels between the two groups
组别 | GDF-15/(ng/L) | S100β/(μg/L) | ||||
---|---|---|---|---|---|---|
治疗前 | 治疗后 | t | 治疗前 | 治疗后 | t | |
呼吸训练组 | 858.37±86.12 | 567.56±57.17 | 20.336** | 0.24±0.06 | 0.31±0.05 | 6.771* |
联合组 | 869.24±87.01 | 421.43±42.53 | 38.013** | 0.23±0.05 | 0.45±0.06 | 23.454** |
t | 0.687 | 15.884** | 0.669 | 13.342** |
组别 | n | SF-36 | |||||
---|---|---|---|---|---|---|---|
治疗前 | 治疗后 | t | |||||
呼吸训练组 | 60 | 65.75±6.76 | 72.46±7.46 | 5.169** | |||
联合组 | 60 | 67.82±6.90 | 87.17±8.83 | 13.707** | |||
t | 1.659 | 9.863** | |||||
组别 | GAD-7 | ||||||
治疗前 | 治疗后 | t | |||||
呼吸训练组 | 17.89±2.14 | 14.87±1.84 | 8.155** | ||||
联合组 | 17.78±2.08 | 9.27±0.09 | 31.365** | ||||
t | 0.286 | 23.484** |
Tab.7 Comparison of SF-36 and GAD-7 scores between the two groups
组别 | n | SF-36 | |||||
---|---|---|---|---|---|---|---|
治疗前 | 治疗后 | t | |||||
呼吸训练组 | 60 | 65.75±6.76 | 72.46±7.46 | 5.169** | |||
联合组 | 60 | 67.82±6.90 | 87.17±8.83 | 13.707** | |||
t | 1.659 | 9.863** | |||||
组别 | GAD-7 | ||||||
治疗前 | 治疗后 | t | |||||
呼吸训练组 | 17.89±2.14 | 14.87±1.84 | 8.155** | ||||
联合组 | 17.78±2.08 | 9.27±0.09 | 31.365** | ||||
t | 0.286 | 23.484** |
组别 | n | 舌头水肿 | 头痛 | 眩晕 | 感染 | 总不良反应 |
---|---|---|---|---|---|---|
呼吸训练组 | 60 | 1(1.67) | 0 | 2(3.33) | 1(1.67) | 4(6.67) |
联合组 | 60 | 1(1.67) | 0 | 1(1.67) | 1(1.67) | 3(5.00) |
χ2 | 0.000 |
Tab.8 Comparison of the incidence of adverse reactions between the two groups
组别 | n | 舌头水肿 | 头痛 | 眩晕 | 感染 | 总不良反应 |
---|---|---|---|---|---|---|
呼吸训练组 | 60 | 1(1.67) | 0 | 2(3.33) | 1(1.67) | 4(6.67) |
联合组 | 60 | 1(1.67) | 0 | 1(1.67) | 1(1.67) | 3(5.00) |
χ2 | 0.000 |
[1] | KANDEL A, ARJYAL A, KARMACHARYA B, et al. Pragmatic solutions for the global burden of stroke[J]. Lancet Neurol, 2024, 23(4):334. doi:10.1016/S1474-4422(24)00039-5. |
[2] | 乔雨晨, 常红, 王佳妹, 等. 认知功能障碍患者激越行为特点及影响因素分析[J]. 中国现代神经疾病杂志, 2023, 23(4):310-316. |
QIAO Y C, CHANG H, WANG J M, et al. Analysis of the characteristics of agitated behavior and its influencing factors in patients with cognition disorders[J]. Chin J Contemp Neurol Neurosurg, 2023, 23(4):310-316. doi:10.3969/j.issn.1672-6731.2023.04.007. | |
[3] | 姜肖宇, 钱东福. 基于ICF的脑卒中吞咽障碍患者整体功能评估类目研究[J]. 中国康复, 2022, 37(1):37-41. |
JIANG X Y, QIAN D F. Systematic functional assessment items based on ICF for patients with dysphagia after stroke[J]. Chinese Journal of Rehabilitation, 2022, 37(1):37-41. doi:10.3870/zgkf.2022.01.009. | |
[4] | 董芬芬, 刘婷, 武岳. 艾地苯醌联合多巴丝肼片及吡贝地尓缓释片治疗老年PD伴抑郁的疗效及对患者炎症因子、神经细胞因子水平的影响[J]. 海南医学, 2023, 34(14):1977-1981. |
DONG F F, LIU T, WU Y. Efficacy of idebenone combined with levodopa and benserazide hydrochloride tablets and piribedil sustained-release tablets in the treatment of elderly patients with Parkinson's disease and depression and its influence on the levels of inflammatory fact[J]. Hainan Med J, 2023, 34(14):1977-1981. doi:10.3969/j.issn.1003-6350.2023.14.001. | |
[5] | 周菲, 陈明亮, 王艳, 等. 神经肌肉电刺激联合呼吸训练治疗老年脑卒中后吞咽功能的疗效[J]. 中国老年学杂志, 2023, 43(11):2657-2661. |
ZHOU F, CHEN M L, WANG Y, et al. Effect of neuromuscular electrical stimulation combined with respiratory training on swallowing function in elderly patients after stroke[J]. Chinese Journal of Gerontology, 2023, 43(11):2657-2661. doi:10.3969/j.issn.1005-9202.2023.11.028. | |
[6] | 中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国急性缺血性脑卒中诊治指南2018[J]. 中华神经科杂志, 2018, 51(9):666-682. |
Chinese Society of Neurology,Chinese Stroke Society. Chinese guidelines for diagnosis and treatment of acute ischemic stroke 2018[J]. Chinese Journal of Neurology, 2018, 51(9):666-682. doi:10.3760/cma.j.issn.1006-7876.2018.09.004. | |
[7] | 刘存志, 于涛, 陆明霞, 等. 卒中后吞咽困难的筛查与评估[J]. 国外医学(老年医学分册), 2005, 26(3):97-102. |
LIU C Z, YU T, LU M X, et al. Screening and evaluation of dysphagia after stroke[J]. International Journal of Geriatrics, 2005, 26(3):97-102. doi:10.3969/j.issn.1674-7593.2005.03.001. | |
[8] | 国家中医药管理局. 中医病证诊断疗效标准[M]. 南京: 南京大学出版社,1994:159. |
National administration of traditional Chinese medicine. Diagnostic efficacy criteria of TCM syndrome[M]. Nanjing: Nanjing University Press,1994:159. | |
[9] | 中国吞咽障碍康复评估与治疗专家共识组. 中国吞咽障碍评估与治疗专家共识(2017年版)第一部分评估篇[J]. 中华物理医学与康复杂志, 2017, 39(12):881-892. |
Chinese Expert consensus group on the assessment and treatment of dysphagia Rehabilitation. The first part of the Chinese expert consensus on the assessment and treatment of dysphagia(2017 edition)[J]. Chinese Journal of Physical Medicine and Rehabilitation, 2017, 39(12):881-892. doi:10.3760/cma.j.issn.0254-1424.2017.12.001. | |
[10] | FEI D, TONG L, CHENG H W, et al. Using physical factor therapy for postoperative patients with cerebral apoplexy voiding dysfunction:A case study[J]. Rehabilitation Science, 2021, 6(2):20-24. doi:10.11648/J.RS.20210602.11. |
[11] | 饶从柏. 脑卒中肢体功能障碍患者应用康复治疗仪联合康复训练的效果[J]. 中外医学研究, 2023, 21(16):145-148. |
RAO C B. Effect of rehabilitation therapy equipment combined with rehabilitation training in stroke patients with limb dysfunction[J]. Chinese and Foreign Medical Research, 2023, 21(16):145-148. doi:10.14033/j.cnki.cfmr.2023.16.036. | |
[12] | LEEM M J, MOON H I, KIM K H. Differences in nutrition and hydration status related to swallowing function and age in acute stroke patients[J]. Journal of Food and Nutrition Research, 2018, 6(12):719-724. doi:10.12691/jfnr-6-12-1. |
[13] | 伍祥容, 代秋蓉, 孙霞. 针灸联合神经肌肉电刺激,导管球囊扩张术对脑卒中后吞咽障碍病人舌骨喉复合体动度,营养状况的影响[J]. 中西医结合心脑血管病杂志, 2023, 21(1):157-160. |
WU X R, DAI Q R, SUN X. Effects of acupuncture and moxibustion combined with neuromuscular electrical stimulation and catheter balloon dilation on hyoid laryngeal complex activities and nutritional status in patients with dysphagia after stroke[J]. Chinese Journal of Integrative Medicine on Cardio/Cerebrovascular Disease, 2023, 21(1):157-160. doi:10.12102/j.issn.1672-1349.2023.01.030. | |
[14] | 秦陶然, 田甜, 王丽莉. 氯氮平片与多巴丝肼片联合治疗帕金森病并精神障碍的效果[J]. 深圳中西医结合杂志, 2023, 2(18):89-92. |
QIN T R, TIAN T, WANG L L. Effect of clozapine tablets combined with dopa and benserazide tablets in the treatment of Parkinson's disease with mental disorders[J]. Shenzhen Journal of Integrated Traditional Chinese and Western Medicine, 2023, 2(18):89-92. doi:10.16458/j.cnki.1007-0893.2023.18.027. | |
[15] | ALVARENGA G M D, SAUER J A Z, LARA L D A D, et al. Impact of association between functional training and respiratory muscle training in elderly:A randomized controlled trial[J]. Journal of Biomedical Science and Engineering, 2023, 16(1):1-15. doi:10.4236/jbise.2023.161001. |
[16] | 景荣华, 周益凡, 孙云丰, 等. 徒手呼吸训练联合电针穴位刺激治疗脑卒中后吞咽障碍的疗效[J]. 世界中西医结合杂志, 2023, 18(4):737-741. |
JING R H, ZHOU Y F, SUN Y F, et al. Effect of unarmed respiratory function training combined with electroacupunc-ture on dysphagia after stroke[J]. World Journal of Integrated Traditional and Western Medicine, 2023, 18(4):737-741. doi:10.13935/j.cnki.sjzx.230421. | |
[17] | 卓钰昕, 叶晨, 秦岭, 等. 脑与心脏的关联性及其共病的潜在机制[J]. 中国现代神经疾病杂志, 2024, 24(2):68-74. |
ZHUO Y X, YE C, QIN L, et al. Brain and heart connection and the potential mechanisms in brain and heart comorbidity[J]. Chin J Contemp Neurol Neurosurg, 2024, 24(2):68-74. doi:10.3969/j.issn.1672-6731.2024.02.002. | |
[18] | HARPAZ D, KOH B, MARKS R S, et al. Point-of-care surface plasmon resonance biosensor for stroke biomarkers nt-probnp and S100β using a functionalized gold chip with specific antibody[J]. Sensors(Basel), 2019, 19(11):2533-2549. doi:10.3390/s19112533. |
[19] | 聂亚蒙, 张小强, 冯鹏展, 等. 依达拉奉右莰醇联合rt-PA静脉溶栓治疗超早期急性脑梗死的疗效及对预后的影响[J]. 天津医药, 2023, 51(7):766-771. |
NIE Y M, ZHANG X Q, FENG P Z, et al. Effects of edaravone dexborneol combined with rt-PA intravenous thrombolysis therapy on efficacy and prognosis of ultra-early acute cerebral infarction[J]. Tianjin Med J, 2023, 51(7):766-771. doi:10.11958/20221607. |
[1] | WEI Chanjuan, XIA Xiaoshuang, FENG Wenjun, LI Xin. The predictive value of neutrophil-to-lymphocyte ratio for poor prognosis in patients with acute ischemic stroke undergoing intravenous thrombolysis [J]. Tianjin Medical Journal, 2025, 53(2): 135-140. |
[2] | YAO Yuting, ZHAO Peng, LI Yan, YAO Yuxin, LIU Minxiao. Observation on the therapeutic effect of stellate ganglion block combined with nicergoline on dysphagia after stroke [J]. Tianjin Medical Journal, 2025, 53(1): 57-60. |
[3] | ZHENG Jiqing, LONG Yaobin, XU Jin. Efficacy of capsaicin combined with repetitive transcranial magnetic stimulation in patients with dysphagia after stroke [J]. Tianjin Medical Journal, 2024, 52(9): 950-953. |
[4] | JIAO Aiju, REN Baolong, ZHANG Chunhua, LI Wenrui, ZHAO Weijing. The predictive value of NIHSS score combined with serum BDNF and IL-6 for post-stroke depression [J]. Tianjin Medical Journal, 2024, 52(9): 963-966. |
[5] | XUE Jing, YUAN Xiaodong, XING Aijun, WANG Lianhui, MA Qian, FU Yongshan, ZHANG Pingshu. Relationship between sleep-wake biorhythm and prognosis in patients with acute ischemic stroke [J]. Tianjin Medical Journal, 2024, 52(6): 614-619. |
[6] | QIAN Hongchun, ZHANG Pingshu, YUAN Xiaodong, YUAN Jianxin, CAO Lingyun, DUAN Liqin. Relationship between cognitive impairment and sleep parameters in stroke patients with obstructive sleep apnea [J]. Tianjin Medical Journal, 2024, 52(6): 619-624. |
[7] | HAN Qin, HAN Xiuli, CHEN Weiran. Analysis of factors affecting depressive disorders after rehabilitation therapy in elderly stroke patients [J]. Tianjin Medical Journal, 2024, 52(6): 639-642. |
[8] | ZHANG Lihong, LI Ruiqing, WANG Yiying, MEI Jinjin, SU Kaiqi, GU Changyu, HUANG Mengling. The mechanism of Du meridian electroacupuncture regulating cystine/glutamate reverse transporter to improve limb spasm after stroke [J]. Tianjin Medical Journal, 2024, 52(5): 463-468. |
[9] | WANG Yue, QUAN Xingmiao, WANG Yu, SONG Chunxia, SHAO Yue, XU Liwei. Influence of Yiqi Shengqing recipe on neuron pyroptosis in ischemic stroke rats by regulating HIF-1α/NLRP3 signal pathway [J]. Tianjin Medical Journal, 2024, 52(4): 350-355. |
[10] | XIAO Yuqian, SUN Kexin, WAN Jun, CHEN Shuying, CHEN Limin, WANG Yan, BAI Yanjie. Research progress of RNA m6A methylation in post-stroke cognitive impairment [J]. Tianjin Medical Journal, 2024, 52(3): 331-336. |
[11] | DING Bo, GONG Jieqin, SHEN Likui. Relationship between serum indexes, pathogenetic condition and prognosis in patients with acute ischemic stroke [J]. Tianjin Medical Journal, 2024, 52(2): 172-176. |
[12] | ZHOU Xiufen, LIU Hui, CHEN Hong, ZHAO Zongbo. Clinical significance of changes in GLI and peripheral blood indicators in SAP patients [J]. Tianjin Medical Journal, 2024, 52(12): 1286-1291. |
[13] | ZHANG Jingjing, ZHAO Wendong, ZHAO Yuan, ZHANG Qingxia, DU Jia, LIU Yanxia. Predictive value of CALLY index for depression after ischemic stroke [J]. Tianjin Medical Journal, 2024, 52(12): 1300-1304. |
[14] | SUN Kexin, XIAO Yuqian, WAN Jun, CHEN Shuying, CHEN Limin, WANG Yan, BAI Yanjie. Research progress of cerebral organoid technology and its application in stroke treatment [J]. Tianjin Medical Journal, 2024, 52(1): 38-43. |
[15] | WANG Wenyi, CHEN Guang. The correlation between excessive daytime sleepiness and sleep disordered breathing in patients after stroke [J]. Tianjin Medical Journal, 2023, 51(12): 1369-1373. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||